| Literature DB >> 35296482 |
Ellen Nolte1, Jemima H Kamano2, Edwine Barasa3, Pablo Perel4, Violet Naanyu5, Anthony Etyang6, Antonio Gasparrini7, Kara Hanson8, Hillary Koros9, Richard Mugo9, Adrianna Murphy10, Robinson Oyando11, Triantafyllos Pliakas7, Vincent Were11, Ruth Willis8.
Abstract
INTRODUCTION: Amid the rising number of people with non-communicable diseases (NCDs), Kenya has invested in strengthening primary care and in efforts to expand existing service delivery platforms to integrate NCD care. One such approach is the AMPATH (Academic Model Providing Access to Healthcare) model in western Kenya, which provides the platform for the Primary Health Integrated Care Project for Chronic Conditions (PIC4C), launched in 2018 to further strengthen primary care services for the prevention and control of hypertension, diabetes, breast and cervical cancer. This study seeks to understand how well PIC4C delivers on its intended aims and to inform and support scale up of the PIC4C model for integrated care for people with NCDs in Kenya. METHODS AND ANALYSIS: The study is guided by a conceptual framework on implementing, sustaining and spreading innovation in health service delivery. We use a multimethod design combining qualitative and quantitative approaches, involving: (1) in-depth interviews with health workers and decision-makers to explore experiences of delivering PIC4C; (2) a cross-sectional survey of patients with diabetes or hypertension and in-depth interviews to understand how well PIC4C meets patients' needs; (3) a cohort study with an interrupted time series analysis to evaluate the degree to which PIC4C leads to health benefits such as improved management of hypertension or diabetes; and (4) a cohort study of households to examine the extent to which the national hospital insurance chronic care package provides financial risk protection to people with hypertension or diabetes within PIC4C. ETHICS AND DISSEMINATION: The study has received approvals from Moi University Institutional Research and Ethics Committee (FAN:0003586) and the London School of Hygiene & Tropical Medicine (17940). Workshops with key stakeholders at local, county, national and international levels will ensure early and wide dissemination of our findings to inform scale up of this model of care. We will also publish findings in peer-reviewed journals. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.Entities:
Keywords: health policy; international health services; primary care
Mesh:
Year: 2022 PMID: 35296482 PMCID: PMC8928278 DOI: 10.1136/bmjopen-2021-056261
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Components of the study
| Study objective and subobjectives | Rationale / hypothesis | Data collection or source | Sampling | Analysis |
|
To assess the quality of leadership and management; levels of stakeholder involvement; adequacy of support mechanisms and resources; ability to adapt the intervention locally; and quality of communication and of monitoring and feedback | Core to the successful adoption and implementation as well as sustaining of organisational change associated with the introduction of the PIC4C model are the various stakeholders affected by the change, their understanding and acceptance and resultant commitment and buy-in to the proposed changes, in particular by front-line staff. | In-depth interviews with Health workers Decision-makers. at three time points each. | Thematic analysis. | |
|
To assess whether and how well the PIC4C model meets the needs of those affected by diabetes and hypertension | There are widely documented challenges of retaining people positively screened for a given NCD in care and adhering to treatment in Kenya. |
Patient survey of experiences with treatment and self-management (PETS). In-depth interviews with patients at three time points. | ||
|
To identify individual-level factors associated with levels of hypertension, diabetes and HIV viral suppression To identify facility-level factors associated with levels of hypertension, diabetes and HIV viral suppression To evaluate temporal trends and the impact of scaling up the PIC4C model on health benefits and potential unintended consequences | The introduction of the PIC4C model will lead to a significant improvement in the management of hypertension and diabetes without adversely affecting HIV management (as measured using HIV viral suppression levels). Primary outcomes, treated as continuous variables, will differ according to diagnosis: systolic blood pressure (hypertension), fasting glucose and HbA1c (diabetes). In patients with more than one diagnosis all relevant outcomes will be considered. Secondary outcomes will include overall cardiovascular risk (as estimated by the WHO Risk Score, | Cohort study of patients with hypertension, diabetes and/or HIV/AIDS. | Estimated sample size of 8000 patients with hypertension, 1000 with diabetes and 1000 with diabetes and hypertension required to detect a reasonable and relevant impact of the PIC4C model for all outcomes (90% power) based on the assumptions: systolic blood pressure change of 5 mm Hg (SD 15) ICC 0.05, HbA1c change 0.37% (SD 1.1%) ICC 0.04. | |
|
To measure the effectiveness of the NHIF national scheme benefit package to provide financial risk protection to individuals with chronic diseases To examine the extent to which the NHIF national scheme benefit package is responsive to the needs of individuals with hypertension, diabetes, cervical and breast cancer To examine how the provider incentives generated by provider payment arrangements of the NHIF national scheme benefit package influence equity, efficiency and quality of care | Enrolment in a health insurance scheme does not always translate into expanded access to healthcare and financial risk protection. |
Cohort study of households with at least one member with hypertension, diabetes or both. In-depth interviews (IDIs) with decision-makers, facility managers and healthcare workers. Focus group discussions (FGDs) with patients with diabetes/hypertension and household heads |
Target sample of n=960 individuals, with n=480 enrolled in NHIF and n=480 not enrolled in NHIF; each subsample to include n=160 individuals with hypertension, n=160 with diabetes and n=160 with both conditions. Estimates based on detection of a 15% point difference in the proportion of catastrophic health expenditure (40% in the control group), a design effect of 1.2 and a two-sided alpha level of 0.05 (80% power and estimated 60% attrition); sample stratified by county and chronic condition. Target sample of 54 IDIs across national, and county and health facility levels in Busia and Trans Nzoia. Four FGDs (each with approximately 10–12 participants), two each in Busia and Trans Nzoia counties, covering rural and urban areas. |
Descriptive statistics; Generalised Estimating Equations with out-of-pocket as dependent and NHIF enrolment as independent variables; estimation of concentration curves and indices. Thematic analysis. |
HbA1c, glycated haemoglobin; ICC, intraclass correlation coefficient; NCD, non-communicable disease; NHIF, National Hospital Insurance Fund; PETS, Patient Experience with Treatment and Self-Management; PIC4C, Primary Health Integrated Care Project for Chronic Conditions.
Figure 1Study design in relation to the guiding conceptual framework. incl., including; NHIF, National Hospital Insurance Fund; PIC4C, Primary Health Integrated Care Project for Chronic Conditions.
Number and type of facilities in Busia and Trans Nzoia counties participating in PIC4C
| Busia ( | Trans Nzoia ( | |
| County hospital ( | 1 | 1 |
| Subcounty hospital ( | 7 | 5 |
| Health centre ( | 10 | 13 |
| Dispensary ( | 22 | 13 |
| Other | – | 1 (private non-profit medical centre) |
|
|
|
|